Product Information
ACTEMRA ACTPEN 162 MG/0.9 ML is a brand product labeled by Genentech, Inc., priced at $1279.0578 per ML under NDC 50242014301. Its NADAC has been published 36 times since Oct 22, 2025.
Strength
162 mg/.9mL
Manufacturer
Genentech, Inc.NDC
50242014301
Classification
Brand
Dosage Form
INJECTION, SOLUTION
Route
SUBCUTANEOUS
Last Updated
5/20/2026
Active Ingredients
TOCILIZUMABApproval Type
Biologic (BLA)
FDA Application
BLA125472On Market Since
11/19/2018
Pharmacological Classes
Price Statistics
The NADAC for ACTEMRA ACTPEN 162 MG/0.9 ML has been published 36 times since Oct 22, 2025, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $1279.0578 per ML |
|---|---|
| All-time high | $1279.0578 (Jun 24, 2026) |
| All-time low | $1273.3755 (Oct 22, 2025) |
| 52-week high | $1279.0578 |
| 52-week low | $1273.3755 |
| Median price | $1279.0578 |
| Average price | $1277.7951 |
| Largest weekly change | +0.4% (Dec 17, 2025) |
| Weeks tracked | 36 |
| Tracking since | Oct 22, 2025 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 22% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of ACTEMRA ACTPEN 162 MG/0.9 ML?
The current National Average Drug Acquisition Cost (NADAC) for ACTEMRA ACTPEN 162 MG/0.9 ML, manufactured by Genentech, Inc., is $1279.0578 per ML (NDC 50242014301), effective Jun 24, 2026.
How has the price of ACTEMRA ACTPEN 162 MG/0.9 ML changed over time?
Over the history we have for it, the NADAC for ACTEMRA ACTPEN 162 MG/0.9 ML has held within roughly two percent of its current level. It has been tracked across 36 weekly CMS publications since Oct 22, 2025.
What are the highest and lowest recorded NADAC prices for ACTEMRA ACTPEN 162 MG/0.9 ML?
Since Oct 22, 2025, the NADAC for ACTEMRA ACTPEN 162 MG/0.9 ML has ranged from a low of $1273.3755 (Oct 22, 2025) to a high of $1279.0578 (Jun 24, 2026), with a median of $1279.0578 per ML.
Are there cheaper alternatives to ACTEMRA ACTPEN 162 MG/0.9 ML?
Yes. 1 NADAC-published product shares the same active ingredient, strength, and dosage form. The lowest-priced option, ACTEMRA 162 MG/0.9 ML SYRINGE, is $1001.1205 per ML — about 22% below ACTEMRA ACTPEN 162 MG/0.9 ML.
Who manufactures ACTEMRA ACTPEN 162 MG/0.9 ML?
ACTEMRA ACTPEN 162 MG/0.9 ML (NDC 50242014301) is labeled by Genentech, Inc., and CMS classifies it as a brand product.